Gain Therapeutics
Price & Volume
Stats
See more52W Range | $1.41-$4.34 |
Market Cap | $93.8M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$8.9M |
Diluted EPS | -$0.61 |
News
See moreYahoo Finance • 23 days ago
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Yahoo Finance • 3 months ago
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
Yahoo Finance • 3 months ago
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
Yahoo Finance • 4 months ago
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
About
CEO | Mr. Gene Mack M.B.A. |
Address | 4800 Montgomery Lane, Bethesda, MD, United States, 20814 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
